Tissue Regenix Group

$80$125

Tissue Regenix Group is a pioneering, international medical technology company, focusing on the development of regenerative products utilizing its two platform technologies, dCELL, addressing soft tissue needs, and BioRinse, providing inductive bone allografts. The company is helping to transform the treatment of patients in three key areas: BioSurgery, Orthopedics & Dental and Cardiac. Also, there is a clinical need for more donor tissue for many surgical procedures. Tissue Regenix will develop and commercialize acellular tissue repair products to meet this need, to ultimately benefit patients.

Report ID:

UMHE21015

Published:

feb-2022

Pages:

14

Industry:

HeadQuatered Country:

United Kingdom

Geography:

Clear
  Get a Free Sample
SKU: UMHE21015 Category:
Scope
Table of content
Companies Mentioned

Scope

“Overview of the company and its product offering
Detailed insight into its Strategy, Vision, Product Portfolio, and Business Headquarters
Information on its recent developments including partnerships, acquisitions, collaborations, and expansions among others
Biography of top management

You can also purchase parts of this report. Do you want to check out a section wise
price list?

“1. Key Facts of the Company
2. Company Mission
3. Company Value
4. Growth Strategy
5. Key Products & Services Offered
6. Infographic
7. Competitors
8. History/Timeline
9. Executive Team
10. SWOT Analysis
11. Company Revenue Split
12. Key Financials
13. Recent Development
13.1 Product Launches
13.2 Partnership
13.3 Business Expansions & Investments

Companies Mentioned

“ERHA Clinic
Aster DM Healthcare
Advanced Tissue
Orthocell
Lumeris